Current situation and immediate steps
A measles outbreak Washington is affecting public health and prompting targeted vaccination and communication efforts. Measles is a highly contagious viral disease that spreads through the air via coughing and sneezing. When an infectious person is in a shared space, others nearby can become exposed. Public health authorities typically respond with case investigations, contact tracing, and clinic-level guidance to limit further spread. This overview explains how measles spreads, how to recognize symptoms, the role of vaccination, and what to do if you may have been exposed.
What measles is and how it spreads
Transmission and infectious period
Measles spreads through respiratory droplets and airborne particles that can remain in the air for hours. People are typically infectious from four days before the rash appears to four days after. Because the virus is very stable in indoor air, susceptible individuals in the same room can become infected even after an infectious person leaves. Crowded indoor settings, schools, and public transit are common environments for transmission. High vaccination coverage reduces spread and protects people who cannot be vaccinated.
- Airborne transmission: infectious aerosols can linger beyond 2 hours.
- Contagious window: from four days before to four days after rash onset.
- High secondary attack rate: up to 90% among unvaccinated close contacts.
Symptoms and when to seek care
Early symptoms include high fever, cough, runny nose, and red, watery eyes. Small white spots (Koplik spots) may appear inside the mouth before the rash. The rash usually starts on the face and spreads downward across the body. Complications can include ear infections, diarrhea, pneumonia, and encephalitis. People with severe breathing difficulties, confusion, or persistent high fever should seek urgent medical care. If you suspect measles, call ahead so clinics can limit exposure to others.
Vaccination and protection
MMR vaccine effectiveness
Two doses of the MMR (measles, mumps, rubella) vaccine are about 97% effective at preventing measles. One dose is about 93% effective. Vaccination not only protects the individual but also helps maintain community immunity, which is especially important to shield newborns, people with weakened immune systems, and others who cannot be vaccinated. Health authorities often recommend that in outbreak settings, certain groups be offered early additional doses where appropriate.
| Doses received | Estimated effectiveness | Context |
|---|---|---|
| 0 doses | No protection | High risk of infection if exposed |
| 1 dose | About 93% | Good individual protection; may be lower in crowded outbreaks |
| 2 doses | About 97% | Strong protection and reduced community spread |
Pregnancy complications if exposed
Measles during pregnancy is associated with risks such as preterm birth and low birth weight. Pregnant people who believe they may have been exposed should contact their healthcare provider promptly. Providers can assess immunity, test for exposure when appropriate, and advise on monitoring. People planning pregnancy who are unsure of their MMR status can check records or serology before conception; vaccination can be given before pregnancy in nonpregnant individuals.
Testing, diagnosis, and isolation
What to expect after exposure or symptoms
Healthcare providers may use a blood test or a cheek swab to detect measles antibodies or viral RNA. If measles is suspected, patients should isolate and inform the clinic or emergency department in advance so infection control measures can be used. Public health departments may request exposure histories and test samples to identify the outbreak strain. Isolation helps limit further transmission while public health teams trace contacts and recommend post-exposure prophylaxis when indicated.
Post-exposure prophylaxis and timing
Options after potential exposure
Depending on the situation, public health officials may recommend measles vaccine or immune globulin for certain people after exposure. Vaccine given within 72 hours of exposure can prevent or reduce severity of disease in some individuals. Immune globulin may be considered for those at increased risk, including some infants, pregnant people, and people with weakened immune systems. Timing and eligibility should be evaluated by a healthcare provider in consultation with public health.
- Vaccine within 72 hours: may prevent or lessen illness.
- Immune globulin: an option for higher-risk individuals within 6 days of exposure.
- Isolation and symptom monitoring: important whether prophylaxis is given.
Safety, side effects, and accessibility
Common reactions after MMR vaccine
The MMR vaccine is widely used and monitored for safety. Most people experience only mild side effects, such as soreness at the injection site, mild fever, or a short-lived rash. Serious adverse events are rare. Allergies to vaccine components are uncommon. Clinics typically observe patients briefly after vaccination and provide guidance on managing minor reactions. The benefits of protection against measles generally outweigh the small risks of side effects.
Common questions about measles outbreak Washington
- How can I confirm I am immune to measles?
Check immunization records for two MMR doses. If records are unavailable, serologic testing can confirm immunity. People born before 1957 are generally considered immune due to widespread natural infection, but documentation is still preferred.
- What to do if I was at a place where transmission occurred?
Contact your healthcare provider or local health department with details on time and location. They can assess your exposure risk and recommend testing or prophylaxis.
- Can I still get measles if I’ve been vaccinated?
Yes, but it is uncommon. Breakthrough infections are typically milder, especially in people who received two doses.
- Where can I get vaccinated during an outbreak?
Local health departments, pharmacies, and many clinics offer MMR vaccine. Public health notices often list vaccination sites and hours.